inguinal hernia
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged 18 years or older. Patients scheduled for unilateral or bilateral inguinal hernia repair. Patients currently receiving antiplatelet therapy (including dual or multiple antiplatelet therapy).
Exclusion criteria
Exclusion criteria: Emergency surgical cases (e.g., incarcerated hernia). Patients with known bleeding disorders or coagulation abnormalities. Patients receiving anticoagulant therapy (e.g., Warfarin, DOACs) or those receiving a combination of antiplatelet and anticoagulant therapy. Patients undergoing robot-assisted inguinal hernia repair. Patients judged unsuitable for the study by the attending physician or investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of postoperative hemorrhagic complications within 30 days after surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| Severity of hemorrhagic complications (Clavien-Dindo classification) Distribution of subcutaneous hematoma Pain and QOL scores (Brief Pain Inventory) Perioperative data (Operative time, intraoperative blood loss, length of stay) Other postoperative complications (SSI, Seroma, Mesh infection, Recurrence, Chronic pain) | — |
Countries
Japan
Contacts
The Jikei University School of Medicine Surgery